Pulmonary arterial hypertension (PAH) is a chronic and progressive disease leading to right
heart failure and ultimately death if untreated. The first classification of PH was proposed in …

Importance Pulmonary arterial hypertension (PAH) is a subtype of pulmonary hypertension
(PH), characterized by pulmonary arterial remodeling. The prevalence of PAH is …

Pulmonary hypertension (PH) is a devastating disease that–if untreated–is characterized by
a poor prognosis. According to the current classification (Venice, 2003), pulmonary arterial …

Group 1 pulmonary hypertension or pulmonary arterial hypertension (PAH) is a rare disease
characterized by proliferation and occlusion of small pulmonary arterioles, leading to …

Pulmonary hypertension is defined as a resting mean pulmonary artery pressure of 25 mm
Hg or above. This review deals with pulmonary arterial hypertension (PAH), a type of …

Pulmonary arterial hypertension (PAH) is a rare disease, but one that continues to cause
significant morbidity and mortality despite much recent therapeutic progress. PAH is one …

Background: Pulmonary arterial hypertension (PAH) is a debilitating chronic disorder of the
pulmonary vasculature characterized by elevated mean pulmonary arterial pressure, right …

Pulmonary arterial hypertension (PAH) is a progressive and fatal lung disease of
multifactorial etiology. Most of the available drugs and FDA-approved therapies for treating …

Pulmonary arterial hypertension (PAH), the first category of pulmonary hypertension, is a
chronic and progressive disorder characterised by angioproliferative vasculopathy in the …

Significant advances in the treatment of pulmonary arterial hypertension (PAH) have
occurred over the last 10 years, starting with the approval of epoprostenol in 1998 …